It is generally agreed that infective endocarditis (IE) is an uncommon disease that still carries significant morbidity and mortality despite advances in diagnosis, antibiotic therapy, and radical surgical treatment. 1,2 IE patients are sick and frequently present with persistent sepsis, renal failure, and peripheral embolization. There is extensive literature on these issues. Accumulated knowledge and experience also confirm that surgery has a role to play in the treatment of IE and should not be regarded as just a strategy to deal with failure of medical therapy. There are a number of problems still unresolved, such as how to address culture-negative cases, the management of visceral embolization, the decision process for reducing the risk of brain embolization if vegetations are present, the impact of IE in patients with congenital heart disease, establishing the appropriate timing for surgery, and the management of stroke, among others.
Some of these issues were discussed recently at the 25th Annual Meeting of the Asian Society of Thoracic and Cardiovascular Surgery in Seoul, South Korea. Surgical treatment of IE has undergone significant changes as part of an earlier-action strategy with more aggressive and radical procedures, as addressed by Marc R Moon from Washington University. Another complex topic, the management of IE in patients with congenital heart disease, was thoroughly discussed by Duke Edward Cameron from John Hopkins, focusing attention on risk exposure over time in this subset of patients. Congenital heart disease patients have specific characteristics that make them a complex subgroups of patients. 3, 4 The surgical management of IE complicated by embolic stroke has also been reviewed in a very elegant contribution by Yanagawa and colleagues. 5 This is of particular interest due to the devastating consequences of both ischemic and hemorrhagic strokes. Furthermore, as stated, there are other serious issues to consider in the pre-, intra-and postoperative settings. The review by Yanagawa and colleagues 5 has given rise to further discussion on a critical issue in the management of IE in current times: because stroke is a paradigmatic example of a critical clinical condition requiring multiple specialist involvement, these authors discussed the importance of a team approach. This is well considered when analyzing IE as a complex clinical entity. Several groups have stressed the importance of dedicated teams in valve disease, and the initiative of the British Valve Society, led by Chambers and colleagues, 6 in defining the role of a valve clinic in a tertiary-care institution, promoted consideration of a more specific working group for IE. 7 The importance of this has been realized by the community, hence the Practice Guidelines by the European Society of Cardiology, endorsed by the European Association for Cardio-thoracic Surgery and the European Association of Nuclear Medicine, include an endocarditis team in their current recommendations for IE. 8 This is also incorporated into the American guidelines. 9 Dedicated endocarditis teams have worked on this for a long time and have demonstrated the benefits of this collective behavior reducing in-hospital and 1-and 3-year mortality in several European countries. [10] [11] [12] Within the discussion of strategies for stroke management, the review by Yanagawa and colleagues 5 highlights the contribution of the Barcelona Working Group on Endocarditis that has focused on collaborative work for over three decades. 13 The Barcelona Endocarditis Team model resulted in a common language used by specialists to address such a clinically complex condition as IE. The work of this dedicated team has brought much knowledge due to shared experiences, policies, and procedures, and has identified some key components when managing these complex patients. Of all the recommendations that followed from this 30-year experience, 13 one to be highlighted is the necessary and mandatory collaboration between tertiary-care institutions and community hospitals or primary care centers serving as referral sites, which definitely results in expedited identification of acute IE cases and initiation of appropriate diagnostic modalities and therapeutic options, according to current agreements. 8 With all of the above in mind, it is probably time for action in Asia with regards to the institution of dedicated teams. Asian physicians and surgeons have contributed in the past to an impactful extent. Institutional or international collaborative efforts in defining epidemiology or trends, contributions to defining the surgical timing for IE complicated by stroke, [14] [15] [16] [17] and specific therapies to decrease the negative impact of intracranial hemorrhage in patients with endocarditis, 18 are good examples of serious and scientifically sound work that has been addressed to improve the management of this serious condition. Other important issues such as the role of very early thrombectomy in embolic strokes will need further investigation. 19 The Barcelona Endocarditis Team model discussed by Yanagawa and colleagues 5 is just a prototype of institutional multidisciplinary cooperative work that has brought benefits to patients, institutions, and professionals, and from which a number of recommendations have emerged. Some may argue that IE is an uncommon disease and that its management might not have the same public impact as more prevalent diseases such as malaria, tuberculosis, or coronary artery disease. However, because endocarditis teams are still not frequently organized, institutions and departments have an open ground to develop any kind of effort resulting in patient benefit. Whatever model is chosen, a multidisciplinary approach is granted.
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